Drreddys Laboratories | RDY - Debt




Drreddys Laboratories reported INR48.54B in Debt for its fiscal quarter ending in September of 2024.

Debt Change Date
ANI Pharmaceuticals USD 320.07M 34.83M Sep/2024
Aurora Cannabis CAD 100.97M 1.13M Sep/2024
Bayer EUR 41.16B 5.42B Sep/2024
Canopy Growth CAD 613.52M 10.01M Sep/2024
Cipla INR 4.61B 980.3M Sep/2024
Corcept Therapeutics USD 6.79M 1.12M Sep/2024
Drreddys Laboratories INR 48.54B 17.87B Sep/2024
GlaxoSmithKline GBP 16.99B 927M Dec/2024
Hikma Pharmaceutical USD 1.28B 85M Jun/2024
Lonza CHF 4.71B 915M Dec/2024
Novartis USD 31.26B 828M Dec/2024
Pacira USD 644.42M 4.17M Sep/2024
Prestige Brands USD 996.95M 54.86M Dec/2024
Richter Gedeon HUF 55.74B 37.12B Jun/2024
Sun Pharmaceuticals INR 25.72B 7.02B Sep/2024
Supernus Pharmaceuticals USD 38.15M 1.82M Sep/2024
Teva Pharmaceutical Industries USD 18.08B 901M Dec/2024